Saturn V Capital Management LP
Q4 2024 13F Holdings
- Locationaustin, TX
- Num holdings
24
- Value ($000)
$255,367
- Date Filed02/14/2025
- Form type13F-HR
- CIK0001964437
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
IRON DISC MEDICINE INC | COM | 254604101 | $32.30M | 13 % | 509,406 | ||
ASND ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | $27.39M | 11 % | 198,977 | ||
MLTX MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | $18.74M | 7 % | 346,111 | ||
CGON CG ONCOLOGY INC | COM | 156944100 | $17.01M | 7 % | 593,262 | ||
PCVX VAXCYTE INC | COM | 92243G108 | $16.72M | 7 % | 204,285 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $16.39M | 6 % | 348,364 | ||
CRGX CARGO THERAPEUTICS INC | COM | 14179K101 | $14.53M | 6 % | 1,007,677 | ||
CELC CELCUITY INC | COM | 15102K100 | $13.92M | 6 % | 1,063,783 | ||
SNDX SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | $13.07M | 5 % | 988,528 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | $12.64M | 5 % | 322,470 |
Rows Per Page
1 - 10 of 2410
- 10
- 50
- 100